Search

Your search keyword '"Hart MK"' showing total 73 results

Search Constraints

Start Over You searched for: Author "Hart MK" Remove constraint Author: "Hart MK" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
73 results on '"Hart MK"'

Search Results

1. Approaches to chronic disease management for asthma and chronic obstructive pulmonary disease: strategies through the continuum of care.

3. Control limits for p control charts with small subgroup sizes.

4. Except and s charts for health care comparisons.

5. Application of variables control charts to risk-adjusted time-ordered healthcare data.

7. Air-fluidized beds or conventional therapy for pressure sores. A randomized trial.

8. A randomized controlled trial of recovery management checkups for primary care patients: Twelve-month results.

9. Using recovery management checkups for primary care to improve linkage to alcohol and other drug use treatment: a randomized controlled trial three month findings.

10. Caribbean Latinx with moderate-severe asthma bear greater asthma morbidity than other Latinx.

11. Cannabis attitudes and patterns of use among followers of the Allergy & Asthma Network.

12. Usefulness of harmonica playing to improve outcomes in patients with chronic obstructive pulmonary disease.

13. Recombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in mice.

14. 13-Deoxytetrodecamycin, a new tetronate ring-containing antibiotic that is active against multidrug-resistant Staphylococcus aureus.

15. Characterization of a Cynomolgus Macaque Model of Pneumonic Plague for Evaluation of Vaccine Efficacy.

16. Phase I/II randomized double-blind study of the safety and immunogenicity of a nonadjuvanted vero cell culture-derived whole-virus H9N2 influenza vaccine in healthy adults.

17. Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses.

18. Histiocytic sarcoma in the bronchoalveolar lavage fluid.

20. Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus.

21. "Cannonballs" and psammoma bodies: unusual cytologic features of metastatic pulmonary small-cell carcinoma in a pleural effusion.

22. Butterfly-shaped nuclei in cerebrospinal fluid relapse of acute promyelocytic leukemia.

23. Clinical development of a Vero cell culture-derived seasonal influenza vaccine.

24. A cell culture-derived influenza vaccine provides consistent protection against infection and reduces the duration and severity of disease in infected individuals.

25. Advanced Development of the rF1V and rBV A/B Vaccines: Progress and Challenges.

26. Designing and testing broadly-protective filoviral vaccines optimized for cytotoxic T-lymphocyte epitope coverage.

27. Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial.

28. Antibody to the E3 glycoprotein protects mice against lethal venezuelan equine encephalitis virus infection.

29. Protection in mice passively immunized with serum from cynomolgus macaques and humans vaccinated with recombinant plague vaccine (rF1V).

30. Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus.

31. Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB.

32. Telemetric analysis to detect febrile responses in mice following vaccination with a live-attenuated virus vaccine.

33. Complex of a protective antibody with its Ebola virus GP peptide epitope: unusual features of a V lambda x light chain.

34. Statistical process control for hospitals: methodology, user education, and challenges.

35. Evolutionary stability of egg trading and parceling in simultaneous hermaphrodites: the chalk bass revisited.

36. Density-dependent habitat selection and performance by a large mobile reef fish.

37. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.

38. X and s charts for health care comparisons.

39. Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins.

40. Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection.

41. Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus.

42. Vaccine research efforts for filoviruses.

43. Histamine metabolism in the visual system of the horseshoe crab Limulus polyphemus.

44. Absence of mycoplasma contamination in the anthrax vaccine.

45. Onset and duration of protective immunity to IA/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice.

46. Ebola virus: the search for vaccines and treatments.

47. Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins.

48. Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein.

49. Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate.

50. Epitopes involved in antibody-mediated protection from Ebola virus.

Catalog

Books, media, physical & digital resources